Related Experiment Video
Updated: May 24, 2025

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
Published on: November 17, 2018
Enhancing immunotherapy with tumour-responsive nanomaterials
Stephen W Linderman1,2, Louis DeRidder3,4, Lucía Sanjurjo5,6
1Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Tumour-responsive nanomaterials offer targeted cancer immunotherapy delivery, overcoming systemic administration issues. These smart materials leverage the tumour microenvironment (TME) to enhance treatment efficacy and improve patient outcomes.
Area of Science:
- Oncology
- Nanomedicine
- Immunotherapy
Background:
- Systemic immunotherapy faces challenges like off-tumour toxicity and limited efficacy due to the immunosuppressive tumour microenvironment (TME).
- Targeted delivery systems are needed to overcome these limitations and enhance therapeutic outcomes.
Purpose of the Study:
- To review the development and application of tumour-responsive nanomaterials for targeted cancer immunotherapy.
- To explore how TME characteristics can be leveraged for enhanced specificity and efficacy of nanomedicine-based immunotherapies.
Main Methods:
- Review of preclinical research and clinical trials on nanomaterial-based immunotherapies.
- Analysis of TME-specific triggers (pH, enzymes, hypoxia, etc.) for nanomaterial cargo release.
- Evaluation of various immunotherapeutic agents delivered via nanomaterials (e.g., checkpoint inhibitors, cytokines, mRNA vaccines).
Main Results:
- Nanomaterials designed to respond to TME cues show promise in targeted drug delivery.
- Successful preclinical studies demonstrate enhanced efficacy and reduced toxicity.
- Several approaches are advancing into clinical trials, indicating therapeutic potential.
Conclusions:
- Tumour-responsive nanomaterials represent a significant advancement in cancer immunotherapy.
- Leveraging TME dynamics offers a strategy to improve specificity and overcome treatment resistance.
- Further research and clinical translation are crucial to realize the full potential of these innovative therapies for improved patient outcomes.
More Related Videos
05:06Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy
Published on: November 10, 2023
08:02Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
Related Concept Videos
Tumor Immunotherapy
The Tumor Microenvironment
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...